Silver in Europe and the Reality Behind Regulatory Change
Over the past year, a growing number of questions have surfaced around the future of silver-based antimicrobial technologies in Europe. Some of these have been framed quite starkly, with suggestions that silver is facing an outright ban under evolving regulatory frameworks. For manufacturers working with antimicrobial additives, particularly in plastics, coatings and textiles, this has understandably created a degree of uncertainty.
The reality, however, is far less dramatic and far more technical.
What is often presented as a single issue is in fact a complex regulatory process involving multiple substances, different chemistries and independent assessments. The starting point for understanding this is recognising that “silver” is not treated as one material within European regulation. Instead, it exists as a wide range of distinct active substances, each with its own chemical identity, toxicological profile and regulatory pathway.
Under the Biocidal Products Regulation (EU) No 528/2012, every active substance used for antimicrobial purposes must undergo a detailed review process. This includes assessment of safety, environmental impact and efficacy within defined product types. Crucially, this process applies separately to each individual silver-based active. Decisions taken on one form of silver do not extend to others, even where they may appear similar at a high level.
This is where much of the confusion originates. Headlines or second-hand interpretations often refer broadly to “silver” without distinguishing between the specific substances under review. In reality, the regulatory position is highly granular.
Many of the silver-based actives used today were originally submitted under the earlier Biocidal Products Directive 98/8/EC and have transitioned into the current BPR review programme. This is a long-established process and, importantly, it allows continued market access while evaluations are ongoing. Products containing these actives can remain on the market until a final decision is reached. This is not an exception or a temporary workaround; it is a fundamental part of how the system is designed to function.
At the same time, it is true that certain specific silver-based substances have received non-approval decisions for defined product types. These include materials such as silver copper sulphate, silver sodium hydrogen zirconium phosphate, silver zeolite and silver zinc zeolite. However, these decisions are tightly scoped. They apply only to those exact substances, within specific product type categories, and do not indicate a broader regulatory move against all silver technologies.
Equally important is what sits outside of these decisions. Technologies that utilise different silver chemistries, or entirely different structures, are not affected by these outcomes. Treating all silver as interchangeable in a regulatory sense is simply incorrect, yet it remains one of the most common misconceptions in the market.
A similar misunderstanding has developed around nano-scale silver. An EU Annex decision addressed the non-approval of silver as a nanomaterial for certain product types, which has contributed to wider concern. However, this applies exclusively to nano forms of silver. Technologies that do not use nano materials fall entirely outside of this scope, yet this distinction is often lost as information is shared and simplified.
Further complexity has been added through recent discussions linked to the REACH Regulation (EC) No 1907/2006 framework, particularly following opinions issued by the European Chemicals Agency’s Risk Assessment Committee. These assessments focus on the intrinsic hazard classification of substances, such as reproductive toxicity or environmental impact. For example, elemental silver has not been classified as carcinogenic or mutagenic, although a reproductive toxicity classification has been proposed. Separate substances, such as silver nitrate, are subject to their own independent evaluations and proposed classifications.
It is important to be clear about what these classifications represent. They describe hazard, not risk, and they do not equate to a ban or restriction on use. Regulatory approval under the Biocidal Products Regulation is based on how a substance is used, the level of exposure and the specific application context. Hazard classification forms part of the picture, but it does not determine market access in isolation.
When viewed in full, the current situation is not one of removal, but of refinement. The European regulatory system is doing exactly what it is designed to do: assessing substances individually, updating classifications where necessary and ensuring that approved technologies meet modern safety and environmental standards.
For manufacturers, the key takeaway is straightforward. Silver-based antimicrobial technologies are not being universally banned in Europe. What matters is the specific active substance, the chemistry behind it and its position within the regulatory review programme.
This places a greater emphasis on understanding supply chains and technology platforms at a deeper level. It is no longer sufficient to ask whether a product contains “silver”; the relevant question is which silver, in what form, and under which regulatory status.
For those working with established, compliant technologies, the outlook remains stable. Silver continues to play an important role in antimicrobial material innovation, supporting product durability, surface protection and long-term performance across a wide range of applications.
The narrative of an impending ban may be attention-grabbing, but it does not reflect the regulatory reality. What we are seeing instead is a more detailed, more precise and ultimately more robust framework for managing antimicrobial technologies in the European market.
Polygiene and Addmaster take regulatory compliance extremely seriously and recognise that it extends far beyond the active substance itself. We work closely with our customers to ensure that products remain compliant at every stage, including at the treated article level. This includes providing guidance on regional regulatory frameworks such as BPR in Europe and EPA requirements in the United States, as well as support on labelling, documentation and permitted claims. As regulatory expectations continue to evolve, we aim to give our partners clarity and confidence in how antimicrobial technologies can be used responsibly and compliantly across different markets.
If you have any questions or would like further guidance, please contact our Chief Regulatory Officer, Lesley Taylor at lesley.taylor@polygiene.com.
Further Reading and Regulatory References
- European Chemicals Agency, https://echa.europa.eu, The central authority responsible for implementing EU chemicals legislation, including biocides and REACH. Provides official updates on substance evaluations, classifications and regulatory processes.
- Biocidal Products Regulation (EU) No 528/2012, https://eur-lex.europa.eu/eli/reg/2012/528/oj/eng, The core framework governing antimicrobial active substances in Europe, including the review programme and approval process.
- REACH Regulation (EC) No 1907/2006, https://eur-lex.europa.eu/eli/reg/2006/1907/oj/eng, Covers classification, labelling and safe use of chemicals, helping explain the difference between hazard classification and regulatory approval.
- ECHA Risk Assessment Committee (RAC), https://echa.europa.eu/about-us/who-we-are/committee-for-risk-assessment, Scientific committee responsible for evaluating hazard classifications of substances such as silver and silver compounds.
- European Commission, https://health.ec.europa.eu/biocides_en, Publishes final decisions on approvals, non-approvals and regulatory updates under BPR.
- BPR Review Programme (existing active substances), https://echa.europa.eu/regulations/biocidal-products-regulation/approval-of-active-substances, Explains how substances submitted under earlier legislation remain on the market while undergoing evaluation.
What Next?
🔗 Follow us on Social Media, here is our LINK TREE
✉️ See how our additive technology can benefit your business by CONTACTING US
🦠 Find out more about Biomaster Antimicrobial Technology HERE
🎥 Watch our video on how Biomaster works WATCH NOW
📰 Subscribe to our Newsletter - SUBSCRIBE
← Back to blog
